IRIDEX CORP
Qualité des données : 100%
IRIX
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
1,00 €
▼
0,04 €
(-3,85%)
Cap. Boursière: 17,83 M
Prix
1,03 €
Cap. Boursière
17,83 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Revenue declined -1,94% annually over 5 years
Negative free cash flow of -2,26 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10,17%
Capital efficient — spends only 0,27% of revenue on capex
Croissance
Revenue Growth (5Y)
-1,94%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)8,23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-82,63%
En dessous de la moyenne du secteur (-53,34%)
ROIC-12,01%
Net Margin-8,42%
Op. Margin-4,88%
Sécurité
Debt / Equity
N/A
Current Ratio1,94
Interest Coverage-44,33
Valorisation
PE (TTM)
-4,02
En dessous de la moyenne du secteur (-1,47)
P/B Ratio3,81
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,0 | -1,5 |
| P/B | 3,8 | 1,6 |
| ROE % | -82,6 | -53,3 |
| Net Margin % | -8,4 | -41,5 |
| Rev Growth 5Y % | -1,9 | 1,8 |
| D/E | — | 0,3 |
Objectif de Cours des Analystes
1 analyste
Buy
Actuel
1,00 €
Objectif
2,75 €
2,75 €
2,75 €
2,75 €
Prévisions
BPA Prévisionnel
0,00 €
CA Est.
56,77 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,00 €
0,00 € – 0,00 €
|
56,77 M | 1 |
| FY2026 |
-0,12 €
-0,12 € – -0,12 €
|
53,23 M | 1 |
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| 2026 Q2 |
-0,02 €
-0,02 € – -0,02 €
|
14,13 M | 1 |
| 2026 Q1 |
-0,07 €
-0,07 € – -0,07 €
|
11,91 M | 1 |
Surprises de Résultats
Derniers 2 trimestres
| Trimestre | BPA Est. | BPA Réel | Surprise |
|---|---|---|---|
| Q42025 | -0,02 € | 0,00 € | +104,0% |
| Q32025 | N/A | -0,09 € | — |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,23% | Revenue Growth (3Y) | 0,77% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1,94% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 52,68 M | Net Income (TTM) | -4,44 M |
| ROE | -82,63% | ROA | -14,81% |
| Gross Margin | 36,50% | Operating Margin | -4,88% |
| Net Margin | -8,42% | Free Cash Flow (TTM) | -2,26 M |
| ROIC | -12,01% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,94 |
| Interest Coverage | -44,33 | Asset Turnover | 1,76 |
| Working Capital | 11,67 M | Tangible Book Value | 2,65 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4,02 | Forward P/E | N/A |
| P/B Ratio | 3,81 | P/S Ratio | 0,34 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -12,67% | ||
| Market Cap | 17,83 M | Enterprise Value | 12,25 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,26 | Revenue / Share | 3,04 |
| FCF / Share | -0,13 | OCF / Share | -0,12 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,27% | FCF Conversion | 50,89% |
| SBC-Adj. FCF | N/A | Growth Momentum | 10,17 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 52,68 M | 48,67 M | 51,87 M | 56,97 M | 36,35 M |
| Net Income | -4,44 M | -8,91 M | -9,57 M | -7,55 M | -6,33 M |
| EPS (Diluted) | -0,26 | -0,54 | -0,59 | -0,47 | -0,46 |
| Gross Profit | 19,23 M | 19,50 M | 21,81 M | 25,37 M | 15,56 M |
| Operating Income | -2,57 M | -8,30 M | -10,01 M | -7,54 M | -6,58 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 3,67 M | 5,45 M | 6,83 M | 7,18 M | 3,28 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 523 000,0 | 584 000,0 | 1,10 M | 485 000,0 | 504 000,0 |
| Interest Expense | 58 000,0 | 146 000,0 | — | — | — |
| Income Tax | 57 000,0 | 68 000,0 | 90 000,0 | 65 000,0 | 26 000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29,15 M | 29,14 M | 34,44 M | 42,29 M | 27,97 M |
| Total Liabilities | 24,23 M | 27,04 M | 24,91 M | 25,06 M | 10,60 M |
| Shareholders' Equity | 4,92 M | 2,10 M | 9,52 M | 17,23 M | 17,37 M |
| Total Debt | 2,70 M | 2,70 M | — | — | 1,25 M |
| Cash & Equivalents | 6,03 M | 2,39 M | 7,03 M | 13,92 M | 11,63 M |
| Current Assets | 25,25 M | 23,56 M | 27,45 M | 35,77 M | 25,36 M |
| Current Liabilities | 13,21 M | 16,56 M | 12,97 M | 12,45 M | 8,68 M |
{"event":"ticker_viewed","properties":{"ticker":"IRIX","listing_kind":"stock","pathname":"/stocks/irix","exchange":"Nasdaq","country":"US"}}